2016年11月23日 / 下午1点37分 / 9 个月前

BRIEF-Biosyent Q3 EPS C$0.08

Nov 23 (Reuters) - Biosyent Inc :

* "expect to see significant growth in 2016 international pharmaceutical sales over 2015"

* Biosyent releases results for third quarter and first nine months of 2016

* Q3 revenue rose 3 percent to C$4.767 million Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below